BS EN ISO 22442-2:2020
$142.49
Medical devices utilizing animal tissues and their derivatives – Controls on sourcing, collection and handling
Published By | Publication Date | Number of Pages |
BSI | 2020 | 28 |
This document specifies requirements for controls on the sourcing, collection, and handling (which includes storage and transport) of animals and tissues for the manufacture of medical devices utilizing materials of animal origin other than in vitro diagnostic medical devices. It applies where required by the risk management process as described in ISO 22442-1.
Selective sourcing is especially important for transmissible spongiform encephalopathy (TSE) risk management, i.e. when utilising animal tissue and/or their derivative originating from bovine, ovine and caprine species, deer, elk, mink or cats.
This document does not cover the utilization of human tissues in medical devices.
This document does not specify a quality management system for the control of all stages of production of medical devices.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
4 | European foreword |
5 | Annex ZA (informative) Relationship between this European Standard and the Essential Requirements of EU Directive 93/42/EEC as amended by Commission Regulation (EU) No 722/2012 |
8 | Foreword |
9 | Introduction |
11 | 1 Scope 2 Normative references 3 Terms and definitions |
12 | 4 General requirements 4.1 General 4.2 Quality system elements |
13 | 4.3 Procedures 4.4 Personnel |
14 | 4.5 Current regulatory requirements and guidance 5 Sourcing 5.1 General 5.2 Species and strain 5.3 Geography |
15 | 5.4 Inspection 5.5 Certification 5.6 Traceability |
16 | 6 Collection 7 Handling 8 Storage, transport and labelling |
18 | Annex A (normative) Additional requirements relating to the application of this document to bovine-sourced materials and other TSE relevant animal species |
24 | Annex B (informative) Certification and attestation |
26 | Bibliography |